Welcome!
circulating tumour cells (CTCs)
Deals, joint ventures & alliances
Biolidics enters into collaboration agreement with Genome Institute of Singapore
SINGAPORE (Sept 10): Biolidics has entered into an agreement with the Genome Institute of Singapore (GIS) to collaborate and develop a new and innovative liquid biopsy test in the field of circulating tumour cells (CTCs) for the assessment of minimal resi
September 10, 2019
Deals, joint ventures & alliances
Biolidics in partnership to expand into China cancer diagnostics market
SINGAPORE (June 25): Medical technology company Biolidics has entered into a partnership with Zhongshan TopGene Medical Laboratory Co to develop and commercialise laboratory-developed tests (LDTs) in the field of circulating tumour cells (CTCs) using Biol
June 25, 2019